Select Page

All News

MeCRU Research Unit Officially launched as Paediatric COVID-19 VACCINE Trial Site

MeCRU Research Unit (MeCRU), at SMU has been officially launched as the research site for Phase III Paediatric COVID-19 Vaccine study conducted by the Numolux Group and Sinovac on 10 September 2021. The very first child and the second one had the honor to receive their jabs which kick started the study.

Related News

Women who work the land with pride

Women who work the land with pride

With a grass cutter in hand and a heart full of purpose, Margaret Kedibone Chiloane is helping shape the gardens and the spirit of Sefako Makgatho Health Sciences University (SMU). As a Machine Operator in the Garden Services unit, she is part of a vital yet often...

Rethinking financial leadership in higher education

Rethinking financial leadership in higher education

Rhendani Mashila’s leadership journey defies convention. A Chartered Accountant [CA(SA)] who built her career in auditing and governance, she now leads transformation in higher education, not through policy or advocacy, but through finance itself.   As the Head...

Breaking circuits and breaking barriers

Breaking circuits and breaking barriers

Every current that flows and every light that glows at Sefako Makgatho Health Sciences University (SMU) bears the signature of Nomsa Mngomezulu. As an Assistant Electrician in the university’s Department of Built Environment, she maintains electrical systems and...